A summary of the latest developments from 12 studies in BTK inhibition in B-cell malignancies presented at EHA2022.
EHA2022 Satellite Symposium: BTK inhibition in B cell malignancies - A critical target for effective and safe treatment
The Satellite Symposium at EHA2022 was chaired by Paolo Ghia joined by Federico Pea, Barbara Eichhorst, Shirley D’Sa and Ramón García Sanz. They discussed next-generation BTK inhibitors in the treatment of B-cell malignancies.
Report on targeted and immune-directed therapies in B-cell malignancies presented at ASCO, EHA and ICML 2021.
Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.